Anzeige
Mehr »
Samstag, 08.11.2025 - Börsentäglich über 12.000 News
Der Trump-Effekt: Kupfer wird kritisch. Vizsla schießt senkrecht!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
296 Leser
Artikel bewerten:
(1)

genae Buys MedicSense

ANTWERP, Belgium and TEL-AVIV, Israel, January 10, 2019 /PRNewswire/ --

genae, Experts in Value-driven Science & Technology for the Medical Industries, today announced the acquisition of MedicSense, a Clinical, Regulatory Affairs and Quality Assurance consultancy firm.

"The vast regulatory and quality assurance expertise of the MedicSense team represents a logical expansion of genae's value chain of services," said Bart Segers, CEO at genae. "Being involved in the early stages of the development process lowers the risk of potential re-engineering and accelerates the time to market, while remaining in compliance with worldwide regulatory requirements."

"Integrating MedicSense in the genae group addresses the needs of the vibrant, high-tech medical device industry and the dynamic regulatory environment," said Adi Ickowicz and Erez Adiv co-founders and CEO's at MedicSense. "This approach favors the entire service industry and represents a major advantage for the larger multi-disciplinary and more comprehensive service providers."

About genae

genae is involved in the development of devices and therapies that change medical practice. With HQ in Antwerp, Belgium, and offices globally, genae serves a client base ranging from publicly traded, strategic players to very early start-ups.

To learn more about genae, please visit http://www.genae.com

About MedicSense

MedicSense specializes in developing dedicated regulatory strategies, from initial product registration to post marketing activities, to assist companies in maneuvering through the stringent and dynamic regulation environment. With a streamlined, highly focused approach, MedicSense has been assisting companies for more than 20 years to get products past regulatory hurdles with innovative and pragmatic solutions.

To learn more about MedicSense, please visit http://www.medicsense.com

Contact
genae associates nv
Bart Segers, co-founder and CEO
+32-3-290-03-06
Justitiestraat 6B, 2018 Antwerp, Belgium
press@genae.com

MedicSense Ltd.
Adi Ickowicz, co-founder and CEO
Erez Adiv, co-founder and CEO
+972-3-923-3666
14 Imber St. Kiryat Arie Petah Tikva, 4951148 Israel
info@medicsense.com

© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.